The power to do more

Faced with Hutchinson-Gilford progeria syndrome (HGPS) or processing-deficient progeroid laminopathies (PL)?

Zokinvy™ (lonafarnib) is a disease-modifying treatment for these ultra-rare diseases.

Photo courtesy of The Progeria Research Foundation.

Zokinvy targets a key step in the disease pathophysiology of HGPS and PL

Starting and staying on Zokinvy matters